Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Allogene Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-11
Sale
2022-08-15
5:40 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
15,000 $16.75 $251,250 218,271
(Direct)
View
2022-08-11
Sale
2022-08-15
5:12 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
15,000 $16.75 $251,250 218,271
(Direct)
View
2022-08-02
Sale
2022-08-02
5:40 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
2,000 $11.97 $23,940 540,257
(Direct)
View
2022-07-05
Sale
2022-07-06
4:16 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
2,000 $11.44 $22,880 542,257
(Direct)
View
2022-06-22
Sale
2022-06-23
4:40 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
10,000 $11.76 $117,600 233,271
(Direct)
View
2022-06-21
Sale
2022-06-22
4:47 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
2,000 $11.18 $22,360 544,257
(Direct)
View
2022-05-19
Sale
2022-05-19
5:40 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
11,500 $7.3993 $85,092 546,257
(Direct)
View
2022-03-15
Sale
2022-03-17
5:59 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
5,169 $7.709 $39,848 320,119
(Direct)
View
2022-03-15
Sale
2022-03-17
5:59 pm
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
8,849 $7.6802 $67,962 413,841
(Direct)
View
2022-03-15
Sale
2022-03-17
5:59 pm
Allogene Therapeutics Inc. ALLO Chang David D
CEO
23,648 $7.6488 $180,879 5,202,848
(Indirect
Direct)
View
2022-03-15
Sale
2022-03-17
5:58 pm
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
11,469 $7.6337 $87,551 1,253,141
(Indirect
Direct)
View
2022-03-15
Sale
2022-03-17
5:58 pm
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
8,698 $7.6326 $66,388 120,430
(Direct)
View
2022-01-12
Purchase
2022-01-14
2:13 pm
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
15,000 $12.6 $189,000 258,885
(Direct)
View
2022-01-12
Purchase
2022-01-14
12:02 pm
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
155,039 $12.6 $1,953,491 7,075,233
(Indirect
Direct)
View
2021-10-01
Sale
2021-10-04
5:55 pm
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
11,507 $24.35 $280,185 323,928
(Direct)
View
2021-09-15
Sale
2021-09-17
4:44 pm
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $24.77 $123,845 533,969
(Direct)
View
2021-09-09
Sale
2021-09-09
5:32 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
5,000 $25.54 $127,700 221,182
(Direct)
View
2021-08-20
Sale
2021-08-23
4:22 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
10,000 $23.47 $234,700 226,182
(Direct)
View
2021-08-16
Sale
2021-08-17
4:05 pm
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $21 $104,994 538,653
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-08
Option Award
2022-07-12
4:48 pm
N/A
2032-07-08
Allogene Therapeutics Inc. ALLO Mayo Stephen
Director
89,815 $0 89,815
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Humer Franz B
Director
44,178 $0 191,892
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
2032-06-15
Allogene Therapeutics Inc. ALLO SATO VICKI L
Director
35,535 $9.62 76,986
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO SATO VICKI L
Director
22,089 $0 76,986
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
44,178 $0 303,063
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
2032-06-15
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
57,624 $0 278,806
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:57 pm
N/A
2032-06-15
Allogene Therapeutics Inc. ALLO Barrett Elizabeth A.
Director
71,070 $0 71,070
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:57 pm
N/A
2032-06-15
Allogene Therapeutics Inc. ALLO MESSEMER DEBORAH M.
Director
71,070 $0 71,070
(Direct)
View
2022-03-31
Other
2022-04-04
4:44 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO PF Equity Holdings 2 B.V.
10% Owner
22,032,040 $0 22,032,040
(Direct)
View
2022-03-14(A)
Other
2022-04-01
5:40 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
4,710,120 $0 14,502,270
(Indirect)
View
2022-03-14
Other
2022-03-31
5:27 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
4,710,121 $0 16,495,448
(Indirect)
View
2022-03-23
Option Award
2022-03-25
5:52 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO Amado Rafael
VP
605,947 $0 926,066
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:51 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO Chang David D
CEO
2,195,512 $0 2,195,512
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:51 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
737,179 $0 737,179
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:50 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
1,458,333 $0 1,458,333
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:49 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
605,947 $0 1,859,088
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:49 pm
N/A
2032-03-23
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
447,873 $0 861,714
(Direct)
View
2022-03-07
Other
2022-03-09
6:26 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
412,618 $0 671,503
(Direct)
View
2022-03-07
Gift
2022-03-09
6:26 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
412,618 $0 671,503
(Direct)
View
2022-01-12
Ownership
2022-01-21
6:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO TPG GP A LLC
WINKELRIED JON
10% Owner
0 $0 18,716,306
(Indirect)
View
2021-09-10
Ownership
2021-09-20
6:25 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO PF Equity Holdings 2 B.V.
10% Owner
0 $0 22,032,040
(Direct)
View
2021-09-15
Exercise
2021-09-17
4:44 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $2.27 533,969
(Direct)
View
2021-09-15
Exercise
2021-09-17
4:44 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $0 533,969
(Direct)
View
2021-08-16
Exercise
2021-08-17
4:05 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $2.27 538,653
(Direct)
View
2021-08-16
Exercise
2021-08-17
4:05 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
5,000 $0 538,653
(Direct)
View
2021-07-30
Option Award
2021-08-03
5:37 pm
N/A
2031-07-30
Allogene Therapeutics Inc. ALLO SATO VICKI L
Director
51,054 $0 51,054
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next